After Pfizer and Serum Institute of India (SII), Bharat Biotech has applied for the emergency use approval for its Coronavirus vaccine, Covaxin. The Hyderabad based company has written to written to central drug regulator seeking emergency use authorization.<br /><br />The vaccine has been developed by Bharat Biotech in collaboration
from india https://ift.tt/2JBRHLT
Monday, December 7, 2020
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment